The initial public offering of Bio Medica Laboratories will open for subscription on Thursday, with grey market activity indicating muted sentiment ahead of the issue launch. The IPO was commanding a grey market premium (GMP) of 0%, suggesting no premium over the upper end of the issue price band in the unofficial market.
The NSE SME issue aims to raise around Rs 52.43 crore through a combination of fresh issue and offer-for-sale components. The IPO consists of a fresh issue of 33.95 lakh shares aggregating to around Rs 47.19 crore and an offer for sale of 3.77 lakh shares worth approximately Rs 5.24 crore.